A new targeted therapy for hard-to-treat chronic lymphocytic leukemia appears to have fewer side effects than a previous therapy.
A P&S research team has found that deficits seen in schizophrenia may be due to a decrease in the number of inhibitory neurons within the brain's memory center.
At the Steven Z. Miller Student Clinician’s Ceremony, the P&S Class of 2018 marked its move from classroom instruction to learning in patient care settings.
A study offers an opportunity to highlight a number of important, ongoing developments in the field of concussion and CTE.
When President Obama signed H.R. 2029, the bill increased funding for the National Institutes of Health by $2 billion. Ross Frommer, Government & Community Affairs, discusses what comes next.
Third-year dental student Elizabeth Fadoju discusses the role of great educators in various stages of life that have encouraged and inspired her.
The Department of Psychiatry's Reiner Center, located on the fifteenth floor of Presbyterian Hospital, opened with a ribbon-cutting ceremony this week.
Higher turnover of blood vessels in brains of people with autism may affect brain networks.
Increased connectivity in the brain's default mode network is a potential precursor, or biomarker, indicating a risk of developing major depressive disorder.
A drug that boosts activity in the brain’s “garbage disposal” system can decrease levels of toxic proteins associated with Alzheimer’s disease and other neurodegenerative disorders and improve cognition in mice.
Nanofiber technology developed at Columbia may improve healing of the tendon-to-bone interface, the weak link in current rotator cuff repairs.